These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6965679)

  • 1. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.
    Doern GV; Morse SA
    J Clin Microbiol; 1980 Feb; 11(2):193-5. PubMed ID: 6965679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of Branhamella catarrhalis and differentiation from Neisseria species in a diagnostic laboratory.
    Ahmad F; Young H; McLeod DT; Croughan MJ; Calder MA
    J Clin Pathol; 1987 Nov; 40(11):1369-73. PubMed ID: 2826546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a ten-minute chromogenic substrate test for identification of pathogenic Neisseria species and Branhamella catarrhalis.
    Janda WM; Sobieski V
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):25-9. PubMed ID: 3132371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.
    Sweeney KG; Verghese A; Needham CA
    Antimicrob Agents Chemother; 1985 Apr; 27(4):499-502. PubMed ID: 3873899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API QuadFERM+ with rapid DNase for identification of Neisseria spp. and Branhamella catarrhalis.
    Janda WM; Zigler KL; Bradna JJ
    J Clin Microbiol; 1987 Feb; 25(2):203-6. PubMed ID: 3102550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter study of the Rosco-Neisseria system for the identification of pathogenic neisserias and Branhamella catarrhalis].
    Pérez JL; Sauca G; Pulido A; Murgui L; García D; Bosch J
    Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):95-7. PubMed ID: 1677275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective medium with DNase test agar and a modified toluidine blue O technique for primary isolation of Branhamella catarrhalis in sputum.
    Soto-Hernandez JL; Nunley D; Holtsclaw-Berk S; Berk SL
    J Clin Microbiol; 1988 Mar; 26(3):405-8. PubMed ID: 3128575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on susceptibility of Branhamella catarrhalis to heavy metals.
    Riley TV; Taylor ML
    J Appl Bacteriol; 1989 Aug; 67(2):185-9. PubMed ID: 2509410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.
    Vaneechoutte M; Verschraegen G; Claeys G; van den Abeele AM
    J Clin Microbiol; 1988 Dec; 26(12):2544-8. PubMed ID: 3147992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Neisseria gonorrhoeae strains isolated on selective and nonselective media.
    Pace PJ; Catlin BW
    Sex Transm Dis; 1986; 13(1):29-39. PubMed ID: 3082019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
    Doern GV; Siebers KG; Hallick LM; Morse SA
    Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Neisseria gonorrhoeae isolates by Martin-Lewis medium. Epidemiology, susceptibility profile, and plasma analysis.
    Miller MA; Anderson P; Parker JW; Rohrer HH
    Br J Vener Dis; 1982 Apr; 58(2):96-100. PubMed ID: 6802441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neisseria gonorrhoeae strains inhibited by vancomycin in selective media and correlation with auxotype.
    Mirrett S; Reller LB; Knapp JS
    J Clin Microbiol; 1981 Jul; 14(1):94-9. PubMed ID: 6790572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Neisseria polysacchareae to antibiotics].
    Dabernat H; Delmas CF; Riou JY; Lareng MB
    Ann Inst Pasteur Microbiol (1985); 1985; 136A(2):233-9. PubMed ID: 3923906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiresistance plasmid from commensal Neisseria strains.
    Pintado C; Salvador C; Rotger R; Nombela C
    Antimicrob Agents Chemother; 1985 Jan; 27(1):120-4. PubMed ID: 3885843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate.
    Aitken JM; Thornley PE
    J Clin Microbiol; 1983 Nov; 18(5):1262-3. PubMed ID: 6643672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
    Forsgren A; Walder M
    Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrageneric and intergeneric transfer of Branhamella catarrhalis beta-lactamase production.
    Kamme C; Wang M; Ståhl S
    Scand J Infect Dis; 1984; 16(2):153-5. PubMed ID: 6610925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in colonial morphology of Neisseria gonorrhoeae after growth on media containing antimicrobial agents.
    James AN; Wende RD; Williams RP
    Appl Microbiol; 1973 Sep; 26(3):248-51. PubMed ID: 4201640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient agar with sodium chloride supplementation for presumptive detection of Moraxella catarrhalis in clinical specimens.
    Nishiyama H; Saito R; Chida T; Sano K; Tsuchiya T; Okamura N
    J Infect Chemother; 2012 Apr; 18(2):219-27. PubMed ID: 22350402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.